Not every drug is right for every person, so its essential to consider your options with a clinician
Until then, the future of BPC research remains firmly centered on the original BPC-157 and its derivatives
Recalls & Warnings August 01, 2013 Maker of Algae Products Warned For Drug Claims, Manufacturing Violations On March 8, 2013, the FDA issued a warning letter to Algaen Corporation following a facility inspection and website review which found statements made about the company's AlgaBerry products to be drug claims
This is because after this period, the bacteriostatic preservative can no longer prevent contamination, often leading to a compromised product that can put the patients at risk
The peptide molecule might be the same on paper, but the product you receive is very different